Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children

NCT00035854 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00035854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
May 31, 2004
Enrollment
13 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections